Safety and pharmacodynamics of rontalizumab in patients with systemic lupus erythematosus: Results of a phase I, placebo‐controlled, double‐blind, dose‐escalation study - Concepedia

Concepedia

Publication | Closed Access

Safety and pharmacodynamics of rontalizumab in patients with systemic lupus erythematosus: Results of a phase I, placebo‐controlled, double‐blind, dose‐escalation study

183

Citations

26

References

2012

Year

Jacqueline McBride, Jenny Jiang, Alexander R. Abbas, Alyssa Morimoto, Jing Li, Romeo Maciuca, Michael J. Townsend, Daniel J. Wallace, William P. Kennedy, Jörn Drappa

Arthritis & Rheumatism

Abstract

The preliminary safety, PK profile, and observed PD effects of rontalizumab support further evaluation of its safety and efficacy in SLE.

References

	Year	Citations

Page 1